SONN:NASDAQ, Sonnet BioTherapeutics Holdings, Inc.

SONN stock overview

Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ) closed at $51.02 on November 20, 2026, up 0.83% on the day. The stock trades 1.6% below its 52-week high of $51.83 and 0.0% above its 52-week low of $51.00. Sonnet BioTherapeutics Holdings, Inc. is part of the Health Care sector.

Key figures

Price
$51.02
Day change
+0.83%
Volume
1,183,905
Average volume
1,120,515
Market cap
8M+
52-week range
$51.00 – $51.83
50-day average
$4.58
200-day average
$3.04

Price action over the past year

In 251 trading sessions since November 20, 2025, SONN closed higher on 2 days (1%). Its best day was November 24, 2025 (+6.59%) and its worst was December 2, 2025 (-59.35%). The stock moved 10% or more in a single session 4 times.

Recent signals

About Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings Inc is a biotechnology company engaged in the development of biologic drugs focused on human antibody binding technology. The firm's pipeline products include SON-080 (low-dose IL-6), SON-081 (low dose IL-6), SON-1010 (IL12-FHAB), and others.

Similar stocks

Find more stocks like SONN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.